BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Xu K, Liu Q, Wu K, Liu L, Zhao M, Yang H, Wang X, Wang W. Extracellular vesicles as potential biomarkers and therapeutic approaches in autoimmune diseases. J Transl Med 2020;18:432. [PMID: 33183315 DOI: 10.1186/s12967-020-02609-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhao J, An Q, Zhu X, Yang B, Gao X, Niu Y, Zhang L, Xu K, Ma D. Research status and future prospects of extracellular vesicles in primary Sjögren's syndrome. Stem Cell Res Ther 2022;13:230. [PMID: 35659085 DOI: 10.1186/s13287-022-02912-1] [Reference Citation Analysis]
2 Desideri E, Ciccarone F, Ciriolo MR, Fratantonio D. Extracellular vesicles in endothelial cells: from mediators of cell-to-cell communication to cargo delivery tools. Free Radic Biol Med 2021;172:508-20. [PMID: 34214634 DOI: 10.1016/j.freeradbiomed.2021.06.030] [Reference Citation Analysis]
3 Tesovnik T, Jenko Bizjan B, Šket R, Debeljak M, Battelino T, Kovač J. Technological Approaches in the Analysis of Extracellular Vesicle Nucleotide Sequences. Front Bioeng Biotechnol 2021;9:787551. [PMID: 35004647 DOI: 10.3389/fbioe.2021.787551] [Reference Citation Analysis]
4 Kim G, Chen X, Yang Y. Pathogenic Extracellular Vesicle (EV) Signaling in Amyotrophic Lateral Sclerosis (ALS). Neurotherapeutics. [DOI: 10.1007/s13311-022-01232-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Claridge B, Lozano J, Poh QH, Greening DW. Development of Extracellular Vesicle Therapeutics: Challenges, Considerations, and Opportunities. Front Cell Dev Biol 2021;9:734720. [PMID: 34616741 DOI: 10.3389/fcell.2021.734720] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Wang X, Phan MM, Sun Y, Koerber JT, Ho H, Chen Y, Yang J. Development of an SPR-based binding assay for characterization of anti-CD20 antibodies to CD20 expressed on extracellular vesicles. Analytical Biochemistry 2022. [DOI: 10.1016/j.ab.2022.114635] [Reference Citation Analysis]
7 Yang Y, Wang Y, Wei S, Zhou C, Yu J, Wang G, Wang W, Zhao L. Extracellular vesicles isolated by size-exclusion chromatography present suitability for RNomics analysis in plasma. J Transl Med 2021;19:104. [PMID: 33712033 DOI: 10.1186/s12967-021-02775-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Iparraguirre L, Alberro A, Hansen TB, Castillo-Triviño T, Muñoz-Culla M, Otaegui D. Profiling of Plasma Extracellular Vesicle Transcriptome Reveals That circRNAs Are Prevalent and Differ between Multiple Sclerosis Patients and Healthy Controls. Biomedicines 2021;9:1850. [PMID: 34944665 DOI: 10.3390/biomedicines9121850] [Reference Citation Analysis]
9 Phan TH, Kim SY, Rudge C, Chrzanowski W. Made by cells for cells - extracellular vesicles as next-generation mainstream medicines. J Cell Sci 2022;135:jcs259166. [PMID: 35019142 DOI: 10.1242/jcs.259166] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Li T, Wang B, Ding H, Chen S, Cheng W, Li Y, Wu X, Wang L, Jiang Y, Lu Z, Teng Y, Su S, Han X, Zhao M. Effect of Extracellular Vesicles From Multiple Cells on Vascular Smooth Muscle Cells in Atherosclerosis. Front Pharmacol 2022;13:857331. [PMID: 35620296 DOI: 10.3389/fphar.2022.857331] [Reference Citation Analysis]
11 Ahmad S, Al-Hatamleh MAI, Mohamud R. Targeting immunosuppressor cells with nanoparticles in autoimmunity: How far have we come to? Cell Immunol 2021;368:104412. [PMID: 34340162 DOI: 10.1016/j.cellimm.2021.104412] [Reference Citation Analysis]
12 Wu F, Gao J, Kang J, Wang X, Niu Q, Liu J, Zhang L. Knowledge Mapping of Exosomes in Autoimmune Diseases: A Bibliometric Analysis (2002–2021). Front Immunol 2022;13:939433. [DOI: 10.3389/fimmu.2022.939433] [Reference Citation Analysis]
13 Gandhi J, Sushma MV, Rengan AK, Naik MN, Mishra DK, Boyinpally SR, Joseph J. Proteomic profiling of exosomes in a mouse model of Candida albicans endophthalmitis. Exp Cell Res 2022;:113222. [PMID: 35618014 DOI: 10.1016/j.yexcr.2022.113222] [Reference Citation Analysis]